Dr. Shallis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 York St
New Haven, CT 06510Phone+1 203-688-4242Fax+1 203-785-4116
Education & Training
Rutgers Robert Wood Johnson Medical SchoolClass of 2014
Certifications & Licensure
CT State Medical License 2017 - 2025
RI State Medical License 2014 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm Start of enrollment: 2023 Jun 27
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 18 citationsA clandestine culprit with critical consequences: Benzene and acute myeloid leukemiaRory M. Shallis, Julian J Weiss, Nicole C. Deziel, Steven D. Gore
Blood Reviews. 2021-05-01 - 6 citationsHypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML.Shai Shimony, Jan Philipp Bewersdorf, Rory M Shallis, Yiwen Liu, Eva J Schaefer
Leukemia. 2024-04-01 - 6 citationsSecond malignancies among older patients with classical myeloproliferative neoplasms treated with hydroxyurea.Rong Wang, Rory M Shallis, Jessica M Stempel, Scott F Huntington, Amer M Zeidan
Blood Advances. 2023-03-14
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
